Indeed, analyses of samples of endometrial cancer patients not only revealed that mPRβ and mPRγ displayed a different subcellular localization in cancerous tissue compared to non-cancerous one but also suggest, based on expression data, these receptors as potential prognostic biomarker for endometrial cancer [149]. Here, PAQR5 is linked to endometrial cancer.